Accendra Health, Inc. (ACH) key performance indicators and operating metrics (26 metrics) from SEC EDGAR filings, earnings calls, and investor decks. First-party data.
| Metric | Latest Value | Period |
|---|---|---|
| Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization | 58.4M | FY2026-Q1 |
| Adjusted Net Income from Continuing Operations | -14.3M | FY2026-Q2 |
| Diabetes Product revenue | 198.82M | FY2026-Q2 |
| Home Respiratory Therapy Product revenue | 91M | FY2026-Q2 |
| Ostomy revenue | 55.68M | FY2026-Q2 |
| Product And Service Other revenue | 47.68M | FY2026-Q2 |
| Sleep Therapy Product revenue | 148.58M | FY2026-Q2 |
| Urology revenue | 31.3M | FY2026-Q2 |
| Wound Care revenue | 40.19M | FY2026-Q2 |
| Adjusted Earnings per Share | -0.19 USD_per_share | FY2026-Q2 |
| Additions to Patient Service Equipment and Other Fixed Assets | -41.65M | FY2026-Q1 |
| Patient Service Equipment Capital Expenditures | 43.8M | FY2026-Q2 |
| Proceeds from Sale of Patient Service Equipment | 15.3M | FY2026-Q2 |
| Revenue | 697.3M | FY2025-Q3 |
Back to ACH overview · ACH earnings · ACH holders
Data sourced from U.S. SEC EDGAR filings, earnings call transcripts, and investor decks. Not personalized investment advice.